Personalized Medicine Progresses
Notable breakthroughs in personalized medicine continue, but reimbursement hurdles and regulation concerns have posed occasional setbacks.
Read MorePosted by Jenny Lower | Jun 13, 2014 | Dementias & Alzheimer’s, Heart Disease, Molecular Diagnostics |
Notable breakthroughs in personalized medicine continue, but reimbursement hurdles and regulation concerns have posed occasional setbacks.
Read MorePosted by Jenny Lower | Jun 13, 2014 | Sexually Transmitted Diseases |
Today’s STD and HIV testing devices strive to deliver rapid results in a variety of clinical settings. Some offer advances never seen before.
Read MorePosted by Jenny Lower | Jun 3, 2014 | Electrolytes, Uncategorized |
New products include the Hematek 3000 hematology analyzer from Siemens Healthcare Diagnostics, CoolCell alcohol-free cell-freezing containers from Biocision, and the Prostate Health Index from Beckman Coulter Diagnostics.
Read MorePosted by Steve Halasey | Jun 3, 2014 | Blood Banking, Hematology & Serology, Molecular Diagnostics, Transfusion & Transplantation Tests |
FDA has approved the PreciseType HEA test by Immucor as the first agency-approved molecular assay to generate genetic matching information for use in blood banking and transfusion medicine to prevent alloimmunization and transfusion reactions.
Read MorePosted by Steve Halasey | May 27, 2014 | Molecular Diagnostics |
Molecular diagnostics company OpGen Inc has launched a molecular-based test that can quickly and reliably identify patients at risk for harboring serious disease-causing microbes that can resist even the strongest antibiotics.
Read More